Navigation Links
Endologix Comments on Alleged Patent Infringement
Date:10/8/2009

IRVINE, Calif., Oct. 8 /PRNewswire-FirstCall/ -- Endologix, Inc. (Nasdaq: ELGX), developer of minimally invasive treatments for aortic disorders, acknowledged today that it has become aware that Cook Medical has filed a lawsuit against Endologix in the United States District Court alleging that Endologix infringes two of Cook's U.S. patents.

John McDermott, Endologix President and Chief Executive Officer, said, "We have just become aware of the lawsuit filed by Cook alleging that Endologix infringes two of Cook's patents, one of which was granted in 1991 and the other in 1998. The patent granted in 1991 expires next week. Together with our patent counsel, we are conducting a thorough evaluation and will provide more information as soon as available."

About Endologix, Inc.

Endologix, Inc. develops and manufactures minimally invasive treatments for aortic disorders. The Company's flagship product is the Powerlink® System, which is an endovascular stent graft for the treatment of abdominal aortic aneurysms (AAA). AAA is a weakening of the wall of the aorta, the largest artery in the body, resulting in a balloon-like enlargement. Once AAA develops, it continues to enlarge and, if left untreated, becomes increasingly susceptible to rupture. Additional information can be found on Endologix's Web site at www.endologix.com.

Forward-Looking Statements

Except for historical information contained herein, this news release contains forward-looking statements, specifically related to the alleged claims of infringement. Please refer to the Company's Annual Report on Form 10-K for the year ended December 31, 2008, and the Company's other filings with the Securities and Exchange Commission, for more detailed informatio
'/>"/>

SOURCE Endologix, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. ViroPharma Submits Comments on Vancocin(R) Draft Bioequivalence Guidance
2. ACRO Comments on NEJM Article on Globalization of Clinical Research
3. Arpida Comments on FDAs Anti-infective Drugs Advisory Committee Outcome
4. SuperGen Comments on Preliminary Efficacy Update on EORTC Phase 3 Trial of Dacogen(R) Versus Supportive Care in Patients With Myelodysplastic Syndromes
5. Arpida Provides Further Comments on the Pivotal Phase III Trials
6. Pediatric Pulmonary Expert Comments on Study of Lung Transplants for Cystic Fibrosis
7. GeoVax Labs, Inc. Comments on Discontinuance of Mercks HIV Vaccine Trial
8. GlaxoSmithKline and U.S. Patent and Trademark Office File a Motion to Dismiss Litigation Over Final Regulations
9. Caraco Pharmaceutical Laboratories, Ltd. Closes Asset Purchase Agreement with Forest Laboratories, Inc. to Settle Lexapro(R) (escitalopram oxalate) ANDA Patent Litigation
10. Biostar Pharmaceuticals, Inc. Receives Patent for Aoxing Ganbao
11. United States Patent Office Allows Claims Covering the Approved Administration of Kuvan with Food
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/18/2014)... LONDON , Sept. 18, 2014 /PRNewswire/ ... Competition for innovation, increasing clinical development costs, new ... the fast-changing environment are important factors driving industry ... clinical trial costs continue to rise due to ... Studies conducted by industry think tanks suggest each ...
(Date:9/18/2014)... -- Decision Resources Group finds that Regeneron,s Eylea, the most ... wet AMD, is equally likely to be covered on ... is the standard of care for wet AMD. Of ... not identify a clear clinical or economic advantage with ... be listed on tier 1 or 2 on Medicare ...
(Date:9/18/2014)... 18, 2014  Zacks.com announces the list of stocks ... Equity Research analysts discuss the latest news and events ... in the blog include the Avanir Pharmaceuticals (Nasdaq: AVNR ... - Free Report ), Orexigen (Nasdaq: OREX - ... Report ) and Gilead (Nasdaq: GILD - Free ...
Breaking Medicine Technology:Patient Recruitment in Asia Biotech and Pharma Companies 2Patient Recruitment in Asia Biotech and Pharma Companies 3Regeneron's Eylea and Genentech's Lucentis Are Equally Likely to be Covered on Commercial and Medicare Advantage Plans for Wet AMD 2Regeneron's Eylea and Genentech's Lucentis Are Equally Likely to be Covered on Commercial and Medicare Advantage Plans for Wet AMD 3The Zacks Analyst Blog Highlights: Avanir Pharmaceuticals, NPS Pharmaceuticals, Orexigen, Medivation and Gilead 2The Zacks Analyst Blog Highlights: Avanir Pharmaceuticals, NPS Pharmaceuticals, Orexigen, Medivation and Gilead 3The Zacks Analyst Blog Highlights: Avanir Pharmaceuticals, NPS Pharmaceuticals, Orexigen, Medivation and Gilead 4The Zacks Analyst Blog Highlights: Avanir Pharmaceuticals, NPS Pharmaceuticals, Orexigen, Medivation and Gilead 5The Zacks Analyst Blog Highlights: Avanir Pharmaceuticals, NPS Pharmaceuticals, Orexigen, Medivation and Gilead 6
... Calif., Nov. 8, 2011 ICU Medical, Inc. (NASDAQ: ... presented this past weekend at the 36th annual meeting ... Anaheim, CA has shown that the company,s ChemoClave® closed ... and patients safe from accidental exposure to hazardous drugs ...
... Nov. 8, 2011 Boston Scientific Corporation (NYSE: ... PLATINUM Long Lesion trial, demonstrating excellent outcomes for the ... patients with long coronary lesions.  Results were presented today ... in La Jolla, California, and Co-Principal Investigator of the ...
Cached Medicine Technology:Breaking Study: ICU Medical, Inc. ChemoClave® System Costs Less to Implement than any Closed System Transfer Device for the Safe Handling of Hazardous Drugs 2Breaking Study: ICU Medical, Inc. ChemoClave® System Costs Less to Implement than any Closed System Transfer Device for the Safe Handling of Hazardous Drugs 3Breaking Study: ICU Medical, Inc. ChemoClave® System Costs Less to Implement than any Closed System Transfer Device for the Safe Handling of Hazardous Drugs 4Boston Scientific's PROMUS Element™ Platinum Chromium Stent Demonstrates Excellent Outcomes in Patients With Long Coronary Lesions 2Boston Scientific's PROMUS Element™ Platinum Chromium Stent Demonstrates Excellent Outcomes in Patients With Long Coronary Lesions 3Boston Scientific's PROMUS Element™ Platinum Chromium Stent Demonstrates Excellent Outcomes in Patients With Long Coronary Lesions 4
(Date:9/19/2014)... September 19, 2014 A recent study ... that older patients with higher levels of vitamin D will ... includes more mobility, better ability to perform daily tasks, and ... at the University of Alberta’s School of Public Health. ... is vitally important to our bodies,” said Dr. Arash Bereliani, ...
(Date:9/19/2014)... Wisconsin (PRWEB) September 19, 2014 QueenBeeTickets.com has ... the Web. With a new tour set to begin on ... to be big sellers on the secure website. , ... for John Mellencamp’s tour at QueenBeeTickets.com. , The Plain Spoken ... all set to obtain seats for a show coming to ...
(Date:9/19/2014)... (PRWEB) September 19, 2014 Indiana Fiber ... Provider, announces the expansion of its Fiber Transport Services, ... in Chicago. By establishing a PoP at Cermak, ... Enterprise organizations looking for high bandwidth fiber transport service ... According to IFN Vice President of Sales and Marketing ...
(Date:9/19/2014)... Monroe, OH (PRWEB) September 19, 2014 ... Family YMCA to bring Health and Well-Being Coach Christi ... fitness career began after surviving brain tumors and gaining weight ... trainer, Hall began weight training and learning about nutrition. One ... and blood sugar, and increased her strength, endurance and cardio. ...
(Date:9/19/2014)... Va. (PRWEB) September 19, 2014 It isn’t ... Forest, a skilled nursing center that offers rehabilitation and assisted ... will this weekend when a young couple marries on site ... with their combined 140 years of marriage have helped showcase ... Sarah Horky, 18, and Dan Eads, 20, may have only ...
Breaking Medicine News(10 mins):Health News:Vitamin D Linked to Improved Quality of Life for Those over 50 2Health News:Vitamin D Linked to Improved Quality of Life for Those over 50 3Health News:John Mellencamp Plain Spoken Tour Tickets: QueenBeeTickets.com Delights Customers with Discount Tickets for Mellencamp’s 80-City 2015 Concert Tour with Carlene Carter 2Health News:Indiana Fiber Network Launches Point-Of-Presence in Chicago Data Center at Cermak 2Health News:Mount Pleasant Retirement Village Partners with Atrium Family YMCA 2Health News:Mount Pleasant Retirement Village Partners with Atrium Family YMCA 3Health News:Young Couple Inspired by Residents Of The Gardens At Warwick Forest To Wed There Saturday 2Health News:Young Couple Inspired by Residents Of The Gardens At Warwick Forest To Wed There Saturday 3
... A new study by researchers at the University at Buffalo ... the September issue of the journal Pain , reveals ... adversity in your life can be protective and beneficial. These ... doctor,s offices or health clinics, says the study,s author Mark ...
... By Amanda Gardner HealthDay Reporter , THURSDAY, Aug. 5 ... see two fingers held up just one foot in front of ... village. Nor could she see an eye chart from a similarly ... laid hands on her and prayed for less than a minute, ...
... dressed in overcoat, pockets filled with stones, walked into a ... Hemingway put his shotgun to his head and pulled the ... 44 years later celebrated authors, all who University of Alberta ... stature was not the fate of a group of 18th ...
... agents may play an important role in maintaining ... studies in Clinical Gastroenterology and Hepatology , ... (AGA) Institute. "Post-surgical recurrence of Crohn,s ... traditional drugs used to treat the naturally occurring ...
... of Louisville has received a $3.15 million grant from ... to support the UofL James Graham Brown Cancer Center ... will be matched with state "Bucks for Brains" funding ... Cancer Research Program (OCRP). "When we established this ...
... OAK BROOK, Ill. August 5, 2010 A ... a split-dosage schedule of bowel (colon) preparation is the ... performed within six to eight hours of the end ... those performed more than eight hours after the end ...
Cached Medicine News:Health News:A little adversity bodes well for those with chronic back pain 2Health News:Can Hands-On Prayer Help Heal? 2Health News:Can Hands-On Prayer Help Heal? 3Health News:Secularization of suicide meant callous mockery of writers' deaths 2Health News:Studies offer encouraging data on preventing Crohn's disease recurrence 2Health News:Studies offer encouraging data on preventing Crohn's disease recurrence 3Health News:UofL receives $3.15 million grant from Helmsley Charitable Trust 2Health News:UofL receives $3.15 million grant from Helmsley Charitable Trust 3Health News:Study shows splitting bowel preparation dosage is most effective cleansing method before colonoscopy 2Health News:Study shows splitting bowel preparation dosage is most effective cleansing method before colonoscopy 3Health News:Study shows splitting bowel preparation dosage is most effective cleansing method before colonoscopy 4
Lyphochek Hemoglobin A2 Control is a human whole blood based product designed to monitor the performance of automated and manual procedures for the measurement of hemoglobin variants, including Hemog...
Liquichek Hematology Control (A) is an assayed hematology control for evaluating the performance of Abbott Cell-Dyn 1600, 1700, 3000, 3500 and 3700 analyzers with 5-part differential technology....
... Control is a bilevel liquid ... performance of the most widely ... A weak positive and a ... monitor the performance of your ...
Liquichek™ Ethanol/Ammonia Control is a liquid product used to monitor ethanol and ammonia test procedures in the clinical laboratory....
Medicine Products: